Table 2.
Association of DLAT expression with clinicopathological characteristics of patients.
| Characteristics | Total(N) | Odds Ratio (OR) | P value |
|---|---|---|---|
| WHO grade (G3 vs. G2) | 467 | 2.040 (1.413–2.957) | <0.001 |
| 1p/19q codeletion (non-codel vs. codel) | 528 | 0.827 (0.573–1.190) | 0.307 |
| Primary therapy outcome (PR&CR vs. PD&SD) | 458 | 0.460 (0.315–0.669) | <0.001 |
| IDH status (Mut vs. WT) | 525 | 0.495 (0.311–0.777) | 0.003 |
| Gender (Male vs. Female) | 528 | 0.898 (0.637–1.266) | 0.541 |
| Race (White vs. Asian&Black or African American) | 517 | 0.659 (0.303–1.383) | 0.276 |
| Age (>40 vs. ≤ 40) | 528 | 1.164 (0.827–1.638) | 0.384 |
| Histological type (Oligoastrocytoma&Oligodendroglioma vs. Astrocytoma) | 528 | 1.050 (0.737–1.496) | 0.787 |
| Laterality (Right vs. Left&Midline) | 523 | 1.156 (0.821–1.631) | 0.406 |